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ReportMutations in the Na/K-ATPase
3 Gene ATP1A3 Are Associated with
Rapid-Onset Dystonia Parkinsonism
gests a trigger initiating a nervous system insult re-
sulting in permanent neurologic disability. We report
the finding of six missense mutations in the gene for
the Na/K-ATPase3 subunit (ATP1A3) in seven unre-
lated families with RDP. Functional studies and struc-
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The Na/K-ATPases (sodium pumps) belong to the
Rapid-onset dystonia-parkinsonism (RDP, DYT12) is P-type ATPase group. Pumps in this group catalyze
a distinctive autosomal-dominant movement disorder active transport of cations across cell membranes and
with variable expressivity and reduced penetrance maintain ionic gradients through hydrolysis of ATP. The
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Table 1. Clinical Characteristics and Mutations in RDP Families
Age of Onset in Onset Period in Number RDP Severity
Codon Probands in Years Proband (Range Affected Scale Range
Family Mutationa Change (Range in Family) in Family) in Family in Familyb Reference
1 T821C I274T 37 14 days 1 3
2 G829A E277K 20 1 day 1 4
3 C1838T T613M 17 2 days 1 2 1
4 C1838T T613M 17 (16–28) Several hours 4 3 2
(mins to 30 days)
5 T2273G I758S 14 (14–45) 30 days 12 2–4 3
(1 hr to 30 days)
6 T2338C F780L 35 (16–35) 30 days 2 3–4
(30–90 days)
7 G2401T D801Y 23 (12–23) 2–3 days 4 2–4 4
References: 1, Linazasoro et al., 2002; 2, Zaremba et al., 2004; 3, Dobyns et al., 1993; 4, Brashear et al., 1997.
a Nucleotide numbering is based on using the A in the start ATG as position 1. The reference cDNA sequence (NM_152296) has 116 bps of
5 UTR before the start ATG.
b 0, unaffected; 1, limb dystonia only; 2, affected arm and bulbar, gait normal; 3, same as 2, with leg involvement but walking unassisted; 4,
same as 2, walking with walker or in wheelchair.
were associated with familial hemiplegic migraine (FHM) (Toyoshima et al., 2000; Toyoshima and Nomura, 2002).
A structural model of 3 was generated based on itstype 2 (De Fusco et al., 2003; Vanmolkot et al., 2003). The
absence of 2 resulted in akinesia and failed respiratory homology to SERCA1a (Sweadner and Donnet, 2001;
Ogawa and Toyoshima, 2002) and on known structuresrhythm generation in newborns in a knockout mouse
model (Moseley et al., 2003), and adult heterozygote for one domain of the 1 and 2 Na/K-ATPase (Hilge
et al., 2003; Hakansson, 2003). SERCA and Na/K-mice displayed degeneration in the amygdala and en-
hanced anxiety behavior (Ikeda et al., 2003). ATPase are 30% identical and 65% similar, and 88%
of Na/K-ATPase residues are scored as aligned withHere, we report mutations in the 3 subunit of the
sodium pump gene (ATP1A3) in patients with RDP and SERCA by gapped BLAST (Sweadner and Donnet,
2001). There is also considerable biochemical and muta-assess the potential pathological role of these mutations
through protein structural analysis, expression studies tional evidence that Na/K-ATPase adopts the same
fold (Sweadner and Donnet, 2001; Ogawa and Toyo-in cell culture, and subcellular localization experiments.
shima, 2002). Na/K-ATPase 1 and 3 are 90% identi-
cal and differ very little in these conserved regions. TheResults and Discussion
disposition on the crystal structures of the SERCA1 resi-
dues corresponding to the mutations is thus highly pre-Several candidate genes in the minimal linked region
were studied based on their putative functions: DPF1, dictive of their locations in the Na/K-ATPase. Figure
2 summarizes the locations of all six mutations in theRYR1, GMFG, SUPT5H, PRX, NUMBL, RABAC1,
ATP1A3, and, as previously reported, GRIK5 (Kamm et Na/K-ATPase in the E1 conformation.
There are three distinct domains on the cytoplasmical., 2004) (human chr 19:43,394,196–47,261,797; July
2003 assembly, www.genome.ucsc.edu). We identified face of the enzyme, and two of them undergo huge
movements during catalysis, driving the rearrangementsix different missense mutations in seven unrelated RDP
families in the ATP1A3 gene (Table 1). In the cases with of the transmembrane spans. Directly above the mem-
brane domain is the phosphorylation (or P) domain (yel-family history (4 through 7; Table 1), the mutations segre-
gated in all affected and obligate carrier members. We low), which extends from transmembrane spans M4 and
M5 and forms the core. The actuator (A) domain (red)identified de novo mutations in two of the sporadic
cases for which we had parental DNA samples (2 and extends from M1, M2, and M3 and undergoes large
movements during the catalytic cycle, such that the3; Table 1) and excluded nonpaternity using several
polymorphic markers on different chromosomes. In ad- three cytoplasmic domains are spread out in the E1
conformation and grouped compactly in E2. The nucleo-dition, cases 3 (de novo) and 4 had the same mutation
(T613M; C1838T), but haplotype analysis across the dis- tide (N) domain (green) emerges from the P domain via
a hinge and folds down over the P domain in the E2ease gene region confirmed that these were indepen-
dent events. All six mutations are located in highly con- conformation (Toyoshima et al., 2000; Toyoshima and
Nomura, 2002). This is thought to position ATP boundserved regions of the protein (Figure 1) and were not
identified in 500 northern European control chromo- to the N domain so that its terminal phosphate reaches
the active site aspartate residue in the P domain. Thesomes. The I758S mutation is located adjacent to a
residue in the homologous region of ATP1A2 mutated terminal phosphate then is transferred covalently to the
aspartate as the first step of ATP hydrolysis. One RDP(L746P) in a FHM2 family (De Fusco et al., 2003) (Fig-
ure 1). mutation, T613M, lies at the edge of the P domain near
the aspartate, and in the E2 conformation it forms a veryThe Na/K-ATPase is closely related to the sarco(en-
do)plasmic reticulum Ca2-ATPase (SERCA). SERCA1 close contact with G539 in the N domain. It seems likely
that this bulky substitution would interfere with en-(the skeletal muscle isoform) has been crystallized in two
different conformations: E1 (Ca2) and E2 (thapsigargin) zyme activity.
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Figure 1. Protein Sequence Alignment of ATPases in the Regions Containing the RDP Mutations
Gray shading highlights the six mutated residues. The boxed amino acid in the human ATP1a2 sequence indicates the site of a mutation
(L764P) associated with familial hemiplegic migraine type 2. All but the final six sequences are Na/K-ATPases. ATP12A is the closely-related
nongastric X, K-ATPase; ATP4A is the gastric H, K-ATPase; SERCA1 is the sarcoplasmic/endoplasmic reticulum Ca2 ATPase with crystal
structures. IonA and PAT1 are related ATPases of Dictyostelium (slime mold, protozoa); PAT1 of Blastocladiella (fungi) is an uncharacterized
relative that shares 27% identity with PAT1 of Dictyostelium. SwissPro or GenBank accession numbers are indicated.
The other five mutations are found in the transmem- predicted to coordinate ions; therefore, it may be on the
pathway for ion movement through the protein.brane domain (purple). Three of these (I274T, E277K,
and I758S) are clustered in the stalk, a bundle ofhelices Thus, all of the RDP mutations in 3 would be pre-
dicted to result in either loss of activity or loss of foldingthat extends from the lipid bilayer to the P domain. All
of these mutations are buried and close to a short  stability or both. This prediction was tested by express-
ing each mutant human 3 in human embryonic kidneyhelix at the base of the P domain (dark blue) that forms
the critical noncovalent contact between domains and (HEK) 293T cells. HEK293 has ATP1A1 (1) activity that
can be inhibited by ouabain (Kockskamper et al., 1997).all involve a change in polarity or charge. It is credible
that these mutations would disrupt either activity or fold- Therefore, to permit inhibition of the endogenous pump
and analyze the viability of the mutant transfected 3ing of the protein. The D801Y mutation of3 is equivalent
to N796 in SERCA1, which is one of the residues that pump, we reduced the natural ouabain sensitivity of 3
by inserting two mutations known to confer ouabainligates Ca2 in the center of the membrane. A side chain
oxygen atom of the asparagine forms part of the ion resistance (Q108R and N119D) (Price et al., 1990). Many
cell lines undergo rapid apoptosis when Na/K-ATPasecoordination site. The residue lies in M6, just one turn
of the helix away from a kink that breaks M6 and forms is inhibited by ouabain, and this forms the basis for
determining whether mutant and ouabain-resistant 3a critical part of the ion binding pocket. Homology mod-
eling of Na/K-ATPase predicts that the equivalent res- Na/K-ATPases have enough expression and activity
to functionally substitute for the endogenous, ouabain-idue, an aspartate, contributes not only to Na site II
but to both sites for K binding (Ogawa and Toyoshima, inhibited enzyme. Cells transfected with ouabain-resis-
tant 3 (3-OR) were able to survive when cultured in2002). Mutations of this residue in SERCA1 are known
to abolish activity (Ogawa and Toyoshima, 2002). The medium containing 10 M ouabain, and 48 hr after the
ouabain challenge showed only 5.4% cell death com-substitution with a bulky tyrosine may also disrupt fold-
ing. The last membrane domain mutation, F780L, lies pared to cells transfected with 3-OR in medium without
ouabain (Figure 3). As expected, cells transfected withcloser to the extracellular surface. Although it is not as
obvious why it should be damaging, mutations of the the wild-type ouabain-sensitive 3 (3-WT) showed ex-
tensive cell death in ouabain-containing medium. Similarequivalent residue in Xenopus 1 (F790C) and of SER-
CA1a (I775A, I775S, but not I775V) are inhibitory (Chen transfection experiments were performed using con-
structs containing each patient mutation in the 3-ORet al., 1996; Rice and MacLennan, 1996; Guennoun and
Horisberger, 2000). It is one turn of the helix closer to backbone. All presented significantly lower survival than
3-OR (p  0.001), indicating that these mutations im-the extracellular surface than N773 and E776, which are
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cellular aqueous surface, distant from all six buried RDP
mutations.
Expression of the protein was obtained in all of the
mutants, but levels of expression were reduced and
seemed to follow the same pattern observed in the cell
viability assays (Figure 4). These observations are con-
sistent with reduced stability and lower recovery of mu-
tant forms. Consequently, both functional deficits and
reduced level may contribute to the failure to replace
1 activity.
To assess whether the localization of mutant pumps
was different from WT pumps, we conducted immuno-
fluorescence studies using Xpress-tagged (Invitrogen)
WT, WT-OR, and mutant OR 3 constructs transiently
transfected into HEK293 cells and found no remarkable
differences (data not shown). In accordance with other
studies (Takeyasu et al., 1988) in which exogenous 
subunit is expressed without additional exogenous 
subunit, much of the nascent a3 appears in ER and
Golgi, but some was observed at the plasma membrane
for all mutant and WT constructs. Qualitatively, this indi-
cates that none of the mutations disrupted the matura-
tion of the Na/K-ATPase.
To date, there is no evidence of widespread neurode-
generation in patients with RDP, but further studies are
necessary to assess this hypothesis. The clinical course
of the majority of the patients, with acute onset of symp-Figure 2. Location of RDP Mutations in Na/K-ATPase 3
toms followed by stabilization, suggests an acute non-A model of 3, shown in ribbon format, was computed based on
homologous structures. The four domains of the protein (N, P, A, progressive neuronal lesion. Some patients have parox-
and membrane) are shown in the E1 (Na binding) conformation. ysmal dystonia and seizures; it is very likely that these
Two of the three predicted ion binding sites in the middle of the mutations lead to abnormal electrical signaling in the
membrane domain are shown with Na ions as cyan spheres. Loops brain. In Drosophila, mutations in the Na/K-ATPase 
that are colored gray have lower homology in SERCA1a, and thus
subunit were associated with neuronal hyperexcitabilitytheir modeled structure is tentative. All mutated residues lie in highly
and seizure-like activity (Palladino et al., 2003), and mu-conserved regions, however. The normal side chain of each disease
residue is shown in spacefill format. tations in ATP1A2 have recently been associated with
benign familial infantile convulsions (Vanmolkot et al.,
2003).
paired the function of the 3-ATPase. Greatest cell death There is considerable experimental evidence for oligo-
was observed with the mutations I758S and D801Y and merization of the Na/K-ATPase, with the formation of
was similar to cells with ouabain-sensitive pump activity either dimers or tetramers of  subunits, accompanied
(3-WT). Mutation I274T seemed to be the least severe, by  and  subunits (Taniguchi et al., 2001; Ivanov et al.,
with the other three mutations displaying an intermedi- 2002; Arystarkhova et al., 2002). Such oligomerization
ate level of cell death (Figure 3). It is unlikely that the would in principle make dominant-negative mutations
mutations created in the constructs to confer ouabain possible. All of the RPD mutated residues, however, are
resistance interact with the RPD mutations to reduce predicted to be buried in one or both conformations,
activity or enhance ouabain sensitivity, because equiva- and nothing about them predicts a role in subunit inter-
lent mutations in 1, 2, and 3 have not been observed actions. The expression studies predict that, in RDP, 3
to impair function in other mutagenesis studies. Addi- activity and expression will be reduced, with a result
equivalent to haploinsufficiency. How this results in thetionally, the ouabain binding mutations are at the extra-
Figure 3. Ouabain Treatment of Transfected
Cells
Histograms represent the percentage of cell
death in HEK293T cells transfected with dif-
ferent ATP1a3 constructs cultured in ouabain
medium, based on the values of four experi-
ments, with 5% error. Cells transfected with
the RDP mutant constructs (lanes 2 through
7) show a higher percentage of cell death
when compared to the control 3-OR con-
struct (lane 1). Mutant constructs in lanes 5
and 7 show the highest percentage of cell
death, similar to that of cells with inhibited
ATPase activity (lane 8).
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Modeling the Structure of the Na/K Pump
A structure for the 3 isoform of the Na/K-ATPase was generated
from the known structures of SERCA1a and the N domains of Na/
K-ATPase 1 and 2 (Toyoshima et al., 2000; Hilge et al., 2003;
Hakansson , 2003). The sequences of SERCA1a, 3, and structurally
aligned portions of the 1 N domain were aligned, and the sequence
alignment was further modified using the structural alignment re-
ported in the crystallographic study of the N domain of 2 (Hakans-
son, 2003). We did not use coordinates from that study since they
Figure 4. Western Blot of HEK293T Cells Showing Differences in have not been made publicly available. Starting from the sequence
Protein Expression of ATP1a3 between Transfected Constructs with alignment and from the published coordinates of SERCA1a (1EUL)
Different Genotypes and the NMR study of the N domain of 1 (1MO8), a structural model
of Na/K-ATPase 3 was calculated using Modeller 6v2 (Marti-(A) ATP1a3 with 20 s exposure; (B) ATP1a3 with 1 min exposure;
Renom et al., 2000). The figure was made using Deep View v3.7.(C) ATP1a1 used as a control for total amount of protein loaded in
each lane, with 10 s exposure. Cells from lanes 2 through 8 were
grown in ouabain-containing medium. Controls in lanes U and 1 were Constructs and Site-Directed Mutagenesis
grown in regular medium. Cells transfected with the RDP mutant We obtained a full-length human ATP1A3 cDNA clone in the ex-
constructs (lanes 2 through 7) showed a lower expression of 3- pression vector pCMV6-XL5 (3-WT) from OriGene (OriGene Tech-
ATPase when compared to the controls transfected with the 3-OR nologies, Inc.) and used site-directed mutagenesis (QuickChange
construct (lanes 1 and 8). Protein from E277K, T613M, I758S, and Site-Directed Mutagenesis Kit, Stratagene) to derive various mutant
D801Y mutant constructs was only detectable at longer exposure constructs. To confer ouabain resistance (OR), we introduced two
time (B). Representative of four experiments. mutations, A323G (Q108R) and A355G (N119D), and obtained the
3-OR cDNA clone. Using 3-OR as template, we introduced one of
the following patient mutations: T821C (3-OR I274T), G829A (3-OR
E277K), C1838T (3-OR T613M), T2273G (3-OR I758S), T2338C
acquisition of dystonic and/or parkinsonian symptoms (3-OR F780L), or G2401T (3-OR D801Y). To obtain tagged con-
after stressful events is likely to be related to an inability structs, 3-WT, 3-OR, and all six 3-OR mutant constructs were
amplified (Pfu Turbo Taq, Stratagene) with the following primers 5-to keep up with a high demand for ion transport activity.
CACAGAATTCGGGGACAAGAAAGATG-3 and 5-CACACTCGAGTFurther, whether other mutations or polymorphisms in
CAGTAGTAGGTTTCC-3. The products were digested with EcoRIATP1A3 represent modifying factors for other forms of
and XhoI (NEB) according to the manufacturer’s instructions and
dystonia, parkinsonism, or epilepsy remains to be inves- subcloned into the pcDNA4/HisMaxC (Invitrogen) expression vector.
tigated. All clones were sequenced in full length. Note: the reference cDNA
sequence in the database (NM_152296) has 116 bps of 5 UTR
sequence before the start ATG. We numbered the mutations using
Experimental Procedures the A in the start ATG as position 1.
Patients
Cell Culture and Transfections
Seven probands clinically diagnosed with RDP according to the
HEK293T cells were grown in Dulbecco’s modified Eagle’s medium
criteria defined by Brashear et al. (1998) and available family mem-
(DMEM) supplemented with 10% fetal bovine serum, 1% penicillin-
bers were screened for mutations (Table 1). Families 3, 5, and 7
streptomycin, and 1% L-glutamine in a 5% CO2 environment at 37C.have been previously published (Linazasoro et al., 2002; Dobyns et
Transient transfections were performed using PolyFect Transfection
al., 1993; Brashear et al., 1997). Clinical information on the probands
Reagent (QIAGEN) according to the manufacturer’s instructions.
and family members is summarized in Table 1. Informed consent
was obtained, and the study was approved by the various institu-
Ouabain Treatmenttional review boards.
Cells were distributed in nine 100 mm plates and were transfected
between 70%–80% confluence. One plate was transfected with the
wild-type ouabain-sensitive (3-WT) cDNA, two plates were trans-Mutation Screening
fected with cDNAs modified only to obtain ouabain resistance (3-DNA was extracted from white blood cells or buccal cells using
OR), and six plates were transfected with 3-OR cDNAs containingstandard methods. The 23 exons of the ATP1A3 gene were amplified
each one of the patient mutations described above. Transfection(primers and conditions in Supplemental Table S1 [http://www.
efficiency was assessed by cotransfection of pDsRed-Express-N1neuron.org/cgi/content/full/43/2/169/DC1]) and the products se-
Vector (Clontech) and estimated at 70%. To inhibit the endogenousquenced by standard dideoxy nucleotide sequencing. For each
sodium pump activity, transfected cells were fed medium containingidentified mutation, we screened 500 control chromosomes by de-
10 M ouabain 36 hr after transfection. One plate transfected withnaturing high performance liquid chromatography (DHPLC) using
3-OR was fed medium without ouabain and was used as a controlthe WAVE Nucleic Acid Fragment Analysis System (Transgenomic,
of the expected number of cells. Two days after the ouabain chal-Omaha, NE). Elution gradients and analysis temperatures for each
lenge, the surviving cells were resuspended and counted with aexon were predicted based on the target sequence using the Trans-
hemacytometer (Fisher Scientific, Co.), and an estimation of cellgenomic WAVEMaker software (Table S1). Mutation positive and
death in each group was obtained by comparing the number ofnegative controls were used in all runs.
surviving cells to those of the control group. The experiment was
repeated four times. In order to verify that the differences in cell
death numbers between the 3-OR cultured in ouabain and theGenotyping
other 3-OR mutants was significant, a 	2 test was performed, andFor confirmation of potential de novo mutations, screening for non-
a p value 
0.05 was considered significant.paternity was performed in the probands and their parents with
the following polymorphic markers: D19S223, D19S400, D19S 417,
D19S 420, D19S 408, D17S785, D18S 976, GATA171C12, D4S2431, Western Blot
Protein (50 g) from transfected and untransfected cell lysates wasD4S3028, and D4S1607. Primers and amplification conditions were
as specified at www.gdb.org and http://www.chlc.org/. The same loaded in 7.5% Tris-HCl polyacrylamide gels. SDS-PAGE was per-
formed for 2 hr at 100 V. For ATP1A3 detection, transblotted nitrocel-markers on chromosome 19 were used for haplotype analysis of
patients who shared the same mutation. Products were analyzed lulose membranes were incubated with the 3-specific XVIF9-G10
monoclonal antibody (Affinity Bioreagents, Golden, CO). Goat anti-on an ABI377 automated sequencer with Genescan and Genotyper
2.5 software (PerkinElmer, Wellesley, MA). mouse (GAM)-HRP conjugate (Bio-Rad) was used as a secondary
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antibody. SuperSignal West Dura Extended Duration Substrate kit de Carvalho Aguiar, P.M., and Ozelius, L.J. (2002). Classification
and genetics of dystonia. Lancet Neurol. 1, 316–325.(Pierce) was used for chemiluminescent protein detection. Antibod-
ies were then removed from the membranes with Restore Western De Fusco, M., Marconi, R., Silvestri, L., Atorino, L., Rampoldi, L.,
Blot Stripping Buffer (Pierce), and membranes were further incu- Morgante, L., Ballabio, A., Aridon, P., and Casari, G. (2003). Haploin-
bated with the 1-specific monoclonal antibody 6F (Developmen- sufficiency of ATP1A2 encoding the Na/K pump alpha2 subunit
tal Studies Hybridoma Bank-Iowa) to detect the endogenous 1 associated with familial hemiplegic migraine type 2. Nat. Genet.
protein. 33, 192–196.
Dobyns, W.B., Ozelius, L.J., Kramer, P.L., Brashear, A., Farlow, M.R.,
Immunocytochemistry Perry, T.R., Walsh, L.E., Kasarskis, E.J., Butler, I.J., and Breakefield,
Twenty-four hours after transfection with the various His tag con- X.O. (1993). Rapid-onset dystonia-parkinsonism. Neurology 43,
structs, cells were plated onto collagen-coated (Vitrogen) coverslips 2596–2602.
and incubated at 37C for another 24 hr. Cells were washed in PBS Grimes, D.A., Han, F., Lang, A.E., St George-Hyssop, P., Racacho,
for 5 min, fixed with 100% methanol for 5 min, rinsed 5  2 min in L., and Bulman, D.E. (2002). A novel locus for inherited myoclonus-
PBS, and then blocked with PBS in 10% FBS for 20 min at room dystonia on 18p11. Neurology 59, 1183–1186.
temperature (RT). Cells were incubated with anti-Xpress monoclonal
Guennoun, S., and Horisberger, J.D. (2000). Structure of the 5thantibody (1:200, Invitrogen) and anti-CD40 polyclonal antibody
transmembrane segment of the Na,K-ATPase  subunit: a cysteine-(5 g/ml, Stressgen) or BiP polyclonal antibody (1:200, Stressgen)
scanning mutagenesis study. FEBS Lett. 482, 144–148.for 1 hr at RT. After washing 2  5 min in PBS, the cells were
Hakansson, K.O. (2003). The crystallographic structure ofincubated with secondary antibodies and Cy3 goat anti-rabbit IgG
Na,K-ATPase N-domain at 2.6 A˚ resolution. J. Mol. Biol. 332, 1175–antibody (1:1200, Jackson Immunoresearch) and AlexaFluor 488-
1182.conjugated goat anti-mouse IgG (1:1000, Molecular Probes), for 1 hr
at RT in the dark. Coverslips were rinsed 2 5 min in PBS, mounted Hilge, M., Siegal, G., Vuister, G.W., Guntert, P., Gloor, S.M., and
onto slides using Gel/Mount aqueous mounting media with anti- Abrahams, J.P. (2003). ATP-induced conformational changes of the
fading reagent (Biomeda Corp), and visualized using a Ziess Axiomat nucleotide-binding domain of Na,K-ATPase. Nat. Struct. Biol. 10,
microscope at 40 magnification with the appropriate filters. 468–474.
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